Global Adjunctive Haemostats 麻豆原创 Research Report 2023

Publication ID:

PB503230341

Publication Date:

March 24, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Adjunctive hemostats are used to assist with the control of intraoperative bleeding. The most common types are flowables, gelatins, thrombins, and oxidized regenerated celluloses (ORCs).
The global Adjunctive Haemostats market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Adjunctive Haemostats is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Adjunctive Haemostats is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Adjunctive Haemostats include Baxter (Perclot), Johnson&Johnson (Ethicon Inc.), Biom'Up, BD, Pfizer, C.R.Bard,Inc., Grena Ltd and Schnell Medical, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Adjunctive Haemostats, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adjunctive Haemostats.
The Adjunctive Haemostats market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Adjunctive Haemostats market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Adjunctive Haemostats manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Baxter (Perclot)
Johnson&Johnson (Ethicon Inc.)
Biom'Up
BD
Pfizer
C.R.Bard,Inc.
Grena Ltd
Schnell Medical
Segment by Type
Liquid Substance
Gelatine
Thrombin
Oxidized Regenerated Cellulose
Powder Hemostat
Segment by Application
Gynecology
Tumors
Cardiovascular
General Surgery
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Adjunctive Haemostats manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Adjunctive Haemostats in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Adjunctive Haemostats 麻豆原创 Overview
1.1 Product Overview and Scope of Adjunctive Haemostats
1.2 Adjunctive Haemostats Segment by Type
1.2.1 Global Adjunctive Haemostats 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 Liquid Substance
1.2.3 Gelatine
1.2.4 Thrombin
1.2.5 Oxidized Regenerated Cellulose
1.2.6 Powder Hemostat
1.3 Adjunctive Haemostats Segment by Application
1.3.1 Global Adjunctive Haemostats 麻豆原创 Value by Application: (2023-2029)
1.3.2 Gynecology
1.3.3 Tumors
1.3.4 Cardiovascular
1.3.5 General Surgery
1.4 Global Adjunctive Haemostats 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Adjunctive Haemostats Revenue 2018-2029
1.4.2 Global Adjunctive Haemostats Sales 2018-2029
1.4.3 Global Adjunctive Haemostats 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Adjunctive Haemostats 麻豆原创 Competition by Manufacturers
2.1 Global Adjunctive Haemostats Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Adjunctive Haemostats Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Adjunctive Haemostats Average Price by Manufacturers (2018-2023)
2.4 Global Adjunctive Haemostats Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Adjunctive Haemostats, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Adjunctive Haemostats, Product Type & Application
2.7 Adjunctive Haemostats 麻豆原创 Competitive Situation and Trends
2.7.1 Adjunctive Haemostats 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Adjunctive Haemostats Players 麻豆原创 Share by Revenue
2.7.3 Global Adjunctive Haemostats 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Adjunctive Haemostats Retrospective 麻豆原创 Scenario by Region
3.1 Global Adjunctive Haemostats 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Adjunctive Haemostats Global Adjunctive Haemostats Sales by Region: 2018-2029
3.2.1 Global Adjunctive Haemostats Sales by Region: 2018-2023
3.2.2 Global Adjunctive Haemostats Sales by Region: 2024-2029
3.3 Global Adjunctive Haemostats Global Adjunctive Haemostats Revenue by Region: 2018-2029
3.3.1 Global Adjunctive Haemostats Revenue by Region: 2018-2023
3.3.2 Global Adjunctive Haemostats Revenue by Region: 2024-2029
3.4 North America Adjunctive Haemostats 麻豆原创 Facts & Figures by Country
3.4.1 North America Adjunctive Haemostats 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Adjunctive Haemostats Sales by Country (2018-2029)
3.4.3 North America Adjunctive Haemostats Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Adjunctive Haemostats 麻豆原创 Facts & Figures by Country
3.5.1 Europe Adjunctive Haemostats 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Adjunctive Haemostats Sales by Country (2018-2029)
3.5.3 Europe Adjunctive Haemostats Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Adjunctive Haemostats 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Adjunctive Haemostats 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Adjunctive Haemostats Sales by Country (2018-2029)
3.6.3 Asia Pacific Adjunctive Haemostats Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Adjunctive Haemostats 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Adjunctive Haemostats 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Adjunctive Haemostats Sales by Country (2018-2029)
3.7.3 Latin America Adjunctive Haemostats Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Adjunctive Haemostats 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Adjunctive Haemostats 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Adjunctive Haemostats Sales by Country (2018-2029)
3.8.3 Middle East and Africa Adjunctive Haemostats Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Adjunctive Haemostats Sales by Type (2018-2029)
4.1.1 Global Adjunctive Haemostats Sales by Type (2018-2023)
4.1.2 Global Adjunctive Haemostats Sales by Type (2024-2029)
4.1.3 Global Adjunctive Haemostats Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Adjunctive Haemostats Revenue by Type (2018-2029)
4.2.1 Global Adjunctive Haemostats Revenue by Type (2018-2023)
4.2.2 Global Adjunctive Haemostats Revenue by Type (2024-2029)
4.2.3 Global Adjunctive Haemostats Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Adjunctive Haemostats Price by Type (2018-2029)
5 Segment by Application
5.1 Global Adjunctive Haemostats Sales by Application (2018-2029)
5.1.1 Global Adjunctive Haemostats Sales by Application (2018-2023)
5.1.2 Global Adjunctive Haemostats Sales by Application (2024-2029)
5.1.3 Global Adjunctive Haemostats Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Adjunctive Haemostats Revenue by Application (2018-2029)
5.2.1 Global Adjunctive Haemostats Revenue by Application (2018-2023)
5.2.2 Global Adjunctive Haemostats Revenue by Application (2024-2029)
5.2.3 Global Adjunctive Haemostats Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Adjunctive Haemostats Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Baxter (Perclot)
6.1.1 Baxter (Perclot) Corporation Information
6.1.2 Baxter (Perclot) Description and Business Overview
6.1.3 Baxter (Perclot) Adjunctive Haemostats Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Baxter (Perclot) Adjunctive Haemostats Product Portfolio
6.1.5 Baxter (Perclot) Recent Developments/Updates
6.2 Johnson&Johnson (Ethicon Inc.)
6.2.1 Johnson&Johnson (Ethicon Inc.) Corporation Information
6.2.2 Johnson&Johnson (Ethicon Inc.) Description and Business Overview
6.2.3 Johnson&Johnson (Ethicon Inc.) Adjunctive Haemostats Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Johnson&Johnson (Ethicon Inc.) Adjunctive Haemostats Product Portfolio
6.2.5 Johnson&Johnson (Ethicon Inc.) Recent Developments/Updates
6.3 Biom'Up
6.3.1 Biom'Up Corporation Information
6.3.2 Biom'Up Description and Business Overview
6.3.3 Biom'Up Adjunctive Haemostats Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Biom'Up Adjunctive Haemostats Product Portfolio
6.3.5 Biom'Up Recent Developments/Updates
6.4 BD
6.4.1 BD Corporation Information
6.4.2 BD Description and Business Overview
6.4.3 BD Adjunctive Haemostats Sales, Revenue and Gross Margin (2018-2023)
6.4.4 BD Adjunctive Haemostats Product Portfolio
6.4.5 BD Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Adjunctive Haemostats Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Pfizer Adjunctive Haemostats Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 C.R.Bard,Inc.
6.6.1 C.R.Bard,Inc. Corporation Information
6.6.2 C.R.Bard,Inc. Description and Business Overview
6.6.3 C.R.Bard,Inc. Adjunctive Haemostats Sales, Revenue and Gross Margin (2018-2023)
6.6.4 C.R.Bard,Inc. Adjunctive Haemostats Product Portfolio
6.6.5 C.R.Bard,Inc. Recent Developments/Updates
6.7 Grena Ltd
6.6.1 Grena Ltd Corporation Information
6.6.2 Grena Ltd Description and Business Overview
6.6.3 Grena Ltd Adjunctive Haemostats Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Grena Ltd Adjunctive Haemostats Product Portfolio
6.7.5 Grena Ltd Recent Developments/Updates
6.8 Schnell Medical
6.8.1 Schnell Medical Corporation Information
6.8.2 Schnell Medical Description and Business Overview
6.8.3 Schnell Medical Adjunctive Haemostats Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Schnell Medical Adjunctive Haemostats Product Portfolio
6.8.5 Schnell Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Adjunctive Haemostats Industry Chain Analysis
7.2 Adjunctive Haemostats Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Adjunctive Haemostats Production Mode & Process
7.4 Adjunctive Haemostats Sales and 麻豆原创ing
7.4.1 Adjunctive Haemostats Sales Channels
7.4.2 Adjunctive Haemostats Distributors
7.5 Adjunctive Haemostats Customers
8 Adjunctive Haemostats 麻豆原创 Dynamics
8.1 Adjunctive Haemostats Industry Trends
8.2 Adjunctive Haemostats 麻豆原创 Drivers
8.3 Adjunctive Haemostats 麻豆原创 Challenges
8.4 Adjunctive Haemostats 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Baxter (Perclot)
Johnson&Johnson (Ethicon Inc.)
Biom'Up
BD
Pfizer
C.R.Bard,Inc.
Grena Ltd
Schnell Medical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.